ASX - By Stock
|
AB1 |
Re:
Ann: Becoming a substantial holder
|
|
Ryphil
|
86 |
29K |
2 |
05/03/18 |
05/03/18 |
ASX - By Stock
|
86
|
29K
|
2
|
|
ASX - By Stock
|
AB1 |
Re:
Ann: Becoming a substantial holder
|
|
Ryphil
|
86 |
29K |
10 |
05/03/18 |
05/03/18 |
ASX - By Stock
|
86
|
29K
|
10
|
|
ASX - By Stock
|
AUZ |
Re:
Murrin vs sconi
|
|
Ryphil
|
24 |
9.7K |
0 |
05/03/18 |
05/03/18 |
ASX - By Stock
|
24
|
9.7K
|
0
|
|
ASX - By Stock
|
CGB |
Re:
Ann: A World First for MCL in Autoimmune Disease Reasearch
|
|
Ryphil
|
278 |
98K |
1 |
05/03/18 |
05/03/18 |
ASX - By Stock
|
278
|
98K
|
1
|
|
ASX - By Stock
|
CGB |
Re:
Ann: A World First for MCL in Autoimmune Disease Reasearch
|
|
Ryphil
|
278 |
98K |
1 |
05/03/18 |
05/03/18 |
ASX - By Stock
|
278
|
98K
|
1
|
|
ASX - By Stock
|
CGB |
Re:
Ann: A World First for MCL in Autoimmune Disease Reasearch
|
|
Ryphil
|
278 |
98K |
9 |
05/03/18 |
05/03/18 |
ASX - By Stock
|
278
|
98K
|
9
|
|
ASX - By Stock
|
CGB |
Re:
Ann: A World First for MCL in Autoimmune Disease Reasearch
|
|
Ryphil
|
278 |
98K |
6 |
05/03/18 |
05/03/18 |
ASX - By Stock
|
278
|
98K
|
6
|
|
ASX - By Stock
|
AB1 |
Re:
Ann: Becoming a substantial holder
|
|
Ryphil
|
86 |
29K |
0 |
05/03/18 |
05/03/18 |
ASX - By Stock
|
86
|
29K
|
0
|
|
ASX - By Stock
|
AB1 |
Re:
Ann: Becoming a substantial holder
|
|
Ryphil
|
86 |
29K |
3 |
05/03/18 |
05/03/18 |
ASX - By Stock
|
86
|
29K
|
3
|
|
ASX - By Stock
|
FGF |
Re:
Ann: Half Year Report and Appendix 4D
|
|
Ryphil
|
240 |
74K |
1 |
05/03/18 |
05/03/18 |
ASX - By Stock
|
240
|
74K
|
1
|
|
ASX - By Stock
|
CGB |
Re:
Ann: A World First for MCL in Autoimmune Disease Reasearch
|
|
Ryphil
|
278 |
98K |
3 |
05/03/18 |
05/03/18 |
ASX - By Stock
|
278
|
98K
|
3
|
|
ASX - By Stock
|
FGF |
Re:
Ann: Half Year Report and Appendix 4D
|
|
Ryphil
|
240 |
74K |
4 |
05/03/18 |
05/03/18 |
ASX - By Stock
|
240
|
74K
|
4
|
|
ASX - By Stock
|
AB1 |
Re:
Ann: Becoming a substantial holder
|
|
Ryphil
|
86 |
29K |
5 |
05/03/18 |
05/03/18 |
ASX - By Stock
|
86
|
29K
|
5
|
|
ASX - By Stock
|
AB1 |
Re:
Ann: Animoca Brands launches Tokyo Casino Project
|
|
Ryphil
|
60 |
21K |
1 |
05/03/18 |
05/03/18 |
ASX - By Stock
|
60
|
21K
|
1
|
|
ASX - By Stock
|
AB1 |
Re:
Ann: Animoca Brands launches Tokyo Casino Project
|
|
Ryphil
|
60 |
21K |
5 |
05/03/18 |
05/03/18 |
ASX - By Stock
|
60
|
21K
|
5
|
|
ASX - By Stock
|
AB1 |
Re:
Ann: Animoca Brands launches Tokyo Casino Project
|
|
Ryphil
|
60 |
21K |
9 |
05/03/18 |
05/03/18 |
ASX - By Stock
|
60
|
21K
|
9
|
|
ASX - By Stock
|
AB1 |
Re:
Ann: Animoca Brands launches Tokyo Casino Project
|
|
Ryphil
|
60 |
21K |
4 |
05/03/18 |
05/03/18 |
ASX - By Stock
|
60
|
21K
|
4
|
|
ASX - By Stock
|
FGF |
Re:
Ann: Half Year Report and Appendix 4D
|
|
Ryphil
|
240 |
74K |
0 |
05/03/18 |
05/03/18 |
ASX - By Stock
|
240
|
74K
|
0
|
|
ASX - By Stock
|
AUZ |
Re:
AUZ Management - BBs Track Record
|
|
Ryphil
|
89 |
47K |
5 |
04/03/18 |
04/03/18 |
ASX - By Stock
|
89
|
47K
|
5
|
|
ASX - By Stock
|
AUZ |
Re:
AUZ Management - BBs Track Record
|
|
Ryphil
|
89 |
47K |
5 |
04/03/18 |
04/03/18 |
ASX - By Stock
|
89
|
47K
|
5
|
|
ASX - By Stock
|
AUZ |
Re:
Whats in a TESLA battery
|
|
Ryphil
|
24 |
11K |
3 |
03/03/18 |
03/03/18 |
ASX - By Stock
|
24
|
11K
|
3
|
|
ASX - By Stock
|
FGF |
Re:
Ann: Half Year Report and Appendix 4D
|
|
Ryphil
|
240 |
74K |
2 |
03/03/18 |
03/03/18 |
ASX - By Stock
|
240
|
74K
|
2
|
|
ASX - By Stock
|
CGB |
Re:
Ann: A World First for MCL in Autoimmune Disease Reasearch
|
|
Ryphil
|
278 |
98K |
7 |
03/03/18 |
03/03/18 |
ASX - By Stock
|
278
|
98K
|
7
|
|
ASX - By Stock
|
CGB |
Re:
Ann: A World First for MCL in Autoimmune Disease Reasearch
|
|
Ryphil
|
278 |
98K |
17 |
03/03/18 |
03/03/18 |
ASX - By Stock
|
278
|
98K
|
17
|
|
ASX - By Stock
|
CGB |
Re:
Ann: A World First for MCL in Autoimmune Disease Reasearch
|
|
Ryphil
|
278 |
98K |
6 |
03/03/18 |
03/03/18 |
ASX - By Stock
|
278
|
98K
|
6
|
|
ASX - By Stock
|
CGB |
Re:
Ann: A World First for MCL in Autoimmune Disease Reasearch
|
|
Ryphil
|
278 |
98K |
14 |
03/03/18 |
03/03/18 |
ASX - By Stock
|
278
|
98K
|
14
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Quarterly Activities and Cashflow Report
|
|
Ryphil
|
67 |
30K |
1 |
03/03/18 |
03/03/18 |
ASX - By Stock
|
67
|
30K
|
1
|
|
ASX - By Stock
|
AB1 |
Re:
FYI
|
|
Ryphil
|
30 |
12K |
3 |
03/03/18 |
03/03/18 |
ASX - By Stock
|
30
|
12K
|
3
|
|
ASX - By Stock
|
CGB |
Re:
Ann: A World First for MCL in Autoimmune Disease Reasearch
|
|
Ryphil
|
278 |
98K |
2 |
03/03/18 |
03/03/18 |
ASX - By Stock
|
278
|
98K
|
2
|
|
ASX - By Stock
|
TAR |
Re:
Afternoon dump
|
|
Ryphil
|
44 |
13K |
0 |
03/03/18 |
03/03/18 |
ASX - By Stock
|
44
|
13K
|
0
|
|
ASX - By Stock
|
AB1 |
Re:
FYI
|
|
Ryphil
|
30 |
12K |
0 |
03/03/18 |
03/03/18 |
ASX - By Stock
|
30
|
12K
|
0
|
|
ASX - By Stock
|
FGF |
Re:
Ann: Half Year Report and Appendix 4D
|
|
Ryphil
|
240 |
74K |
1 |
03/03/18 |
03/03/18 |
ASX - By Stock
|
240
|
74K
|
1
|
|
ASX - By Stock
|
CGB |
Re:
Ann: A World First for MCL in Autoimmune Disease Reasearch
|
|
Ryphil
|
278 |
98K |
6 |
03/03/18 |
03/03/18 |
ASX - By Stock
|
278
|
98K
|
6
|
|
ASX - By Stock
|
CGB |
Re:
Ann: A World First for MCL in Autoimmune Disease Reasearch
|
|
Ryphil
|
278 |
98K |
2 |
02/03/18 |
02/03/18 |
ASX - By Stock
|
278
|
98K
|
2
|
|
ASX - By Stock
|
CGB |
Re:
Ann: A World First for MCL in Autoimmune Disease Reasearch
|
|
Ryphil
|
278 |
98K |
8 |
02/03/18 |
02/03/18 |
ASX - By Stock
|
278
|
98K
|
8
|
|
ASX - By Stock
|
CGB |
Re:
Ann: A World First for MCL in Autoimmune Disease Reasearch
|
|
Ryphil
|
278 |
98K |
2 |
02/03/18 |
02/03/18 |
ASX - By Stock
|
278
|
98K
|
2
|
|
ASX - By Stock
|
CGB |
Re:
Ann: A World First for MCL in Autoimmune Disease Reasearch
|
|
Ryphil
|
278 |
98K |
1 |
02/03/18 |
02/03/18 |
ASX - By Stock
|
278
|
98K
|
1
|
|
ASX - By Stock
|
CGB |
Re:
Ann: A World First for MCL in Autoimmune Disease Reasearch
|
|
Ryphil
|
278 |
98K |
3 |
02/03/18 |
02/03/18 |
ASX - By Stock
|
278
|
98K
|
3
|
|
ASX - By Stock
|
CGB |
Re:
Ann: A World First for MCL in Autoimmune Disease Reasearch
|
|
Ryphil
|
278 |
98K |
2 |
02/03/18 |
02/03/18 |
ASX - By Stock
|
278
|
98K
|
2
|
|
ASX - By Stock
|
CGB |
Re:
Ann: A World First for MCL in Autoimmune Disease Reasearch
|
|
Ryphil
|
278 |
98K |
2 |
02/03/18 |
02/03/18 |
ASX - By Stock
|
278
|
98K
|
2
|
|
ASX - By Stock
|
CGB |
Re:
Ann: A World First for MCL in Autoimmune Disease Reasearch
|
|
Ryphil
|
278 |
98K |
3 |
02/03/18 |
02/03/18 |
ASX - By Stock
|
278
|
98K
|
3
|
|
ASX - By Stock
|
CGB |
Re:
Ann: A World First for MCL in Autoimmune Disease Reasearch
|
|
Ryphil
|
278 |
98K |
3 |
02/03/18 |
02/03/18 |
ASX - By Stock
|
278
|
98K
|
3
|
|
ASX - By Stock
|
CGB |
Re:
Ann: A World First for MCL in Autoimmune Disease Reasearch
|
|
Ryphil
|
278 |
98K |
4 |
02/03/18 |
02/03/18 |
ASX - By Stock
|
278
|
98K
|
4
|
|
ASX - By Stock
|
CGB |
Re:
Ann: A World First for MCL in Autoimmune Disease Reasearch
|
|
Ryphil
|
278 |
98K |
1 |
02/03/18 |
02/03/18 |
ASX - By Stock
|
278
|
98K
|
1
|
|
ASX - By Stock
|
CGB |
Re:
Ann: A World First for MCL in Autoimmune Disease Reasearch
|
|
Ryphil
|
278 |
98K |
4 |
02/03/18 |
02/03/18 |
ASX - By Stock
|
278
|
98K
|
4
|
|
ASX - By Stock
|
AB1 |
Re:
FYI
|
|
Ryphil
|
30 |
12K |
2 |
02/03/18 |
02/03/18 |
ASX - By Stock
|
30
|
12K
|
2
|
|
ASX - By Stock
|
CGB |
Re:
Ann: A World First for MCL in Autoimmune Disease Reasearch
|
|
Ryphil
|
278 |
98K |
10 |
02/03/18 |
02/03/18 |
ASX - By Stock
|
278
|
98K
|
10
|
|
ASX - By Stock
|
BUL |
Re:
T analysis
|
|
Ryphil
|
31 |
13K |
3 |
02/03/18 |
02/03/18 |
ASX - By Stock
|
31
|
13K
|
3
|
|
ASX - By Stock
|
CGB |
Re:
Ann: A World First for MCL in Autoimmune Disease Reasearch
|
|
Ryphil
|
278 |
98K |
3 |
02/03/18 |
02/03/18 |
ASX - By Stock
|
278
|
98K
|
3
|
|
ASX - By Stock
|
AB1 |
Re:
FYI
|
|
Ryphil
|
30 |
12K |
2 |
02/03/18 |
02/03/18 |
ASX - By Stock
|
30
|
12K
|
2
|
|